Ex-BioChemics CEO's SEC Deal Bars Him From Leading Cos.
The former BioChemics Inc. CEO who was accused of lying to investors about the state of the company has agreed to pay the U.S. Securities and Exchange Commission $120,000 and remain...To view the full article, register now.
Already a subscriber? Click here to view full article